Article PDF
Avoid common mistakes on your manuscript.
References
Dept. of Health and Human Services, Washington DC, 1980: Promoting health/preventing disease. Objectives for the nation.
EPI — Information System — Summary for the WHO: European Region WHO, CEIS/90, I. Ed., January 1990 (and other EPI/WHO reports).
Stehr, K. Schutzimpfung gegen Pertussis. In:Spiess, H. (ed.): Schutzimpfungen. Med. Verlagsgesellschaft, Marburg/Lahn 1985, pp. 113–181.
Ada, G.: Vaccine and vaccination. World Health, July 5–7, 1988.
Suchman, E. Action for what? A critique of evaluative research. In:Weiss, C. (ed.): Evaluating social action programmes. Readings in social action and education. Allyn & Bacon, Boston 1972, pp. 52–84.
Salk, D. Polio immunization policy in the United States: A new challenge for a new generation. Am. J. Public Health 78, 3 (1988) 296–300.
Hinman, A. R., Koplan, J. P., Orenstein, W. A., Brink, E. W. Decision analysis and polio immunization policy. Am. J. Public Health 78, 3 (1988) 301–303.
Editorial Diphtheria outbreaks in immunized populations. N. Engl. J. Med. 318, 1 (1988) 41–43.
EPI Overview in European Region, Report on 13th Meeting of the Global Advisory Group. EPI/GAG/WP 5, 7, Geneva 1990.
Galazka, A. M., Lauer, B. A., Henderson, R. A., Keja, J. Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bull. WHO 62, 3 (1984) 357.
WHO Immunization Policies in Europe: Report on a WHO Meeting. Karlovy Vary; Czechoslovakia, 1984. Unedited Document ICP/EPI 001, WHO Regional Office for Europe, Copenhagen 1986.
WHO Consultative Group on Poliomyelitis Vaccines The work of the Consultative Group. Bull. WHO 66 (1988) 143.
Wilson, G. Hazards of immunization. Athlone Press, London 1967.
Centers for Disease Control: Adverse Events Following Immunization, Surveillance Report No. 2 (1986) 1982–1985.
Dittman, S. Immunobiological preparations. in:Dukes, M. N. G. Meyler's side effects of drugs. 11th edition, Elsevier Science Publishers, Amsterdam, New York, Oxford, 1988.
Delarue, F., Delarue, S. La rancon des vaccinations. 6th edition, German translation: Impfungen, der unglaubliche Irrtum. Hirthammer Verlag, München 1990.
Rey, M. Vaccination. Masson, Paris 1980.
WHO: Economic aspects of communicable diseases. Report on a WHO working group in Trier, Sept. 21–23, 1981. Regional Office for Europe, EURO-Reports and Studies, 68 (1982) Copenhagen.
Anonymous: Immunizing the world's children, population reports, 1,5 (1986) 154–186.
John, J.: Where the need is greatest. WHO, December 28–29, 1989.
Enders, G. Schutzimpfungen gegen Masern und Mumps. In:Spiess, H. (ed.): Schutzimpfungen. Med. Verlagsgesellschaft, Marburg/Lahn 1985, pp. 57–72.
Klausing, M. Kosten-Nutzen-Analysen von Schutzimpfungen. In: Schutzimpfungen, Notwendigkeit, Wirkung/Nebenwirkungen, Impfpolitik. Bericht der Tagung des Deutschen Grünen Kreuzes. Med. Verlagsgesellschaft, Marburg/Lahn 1985, pp. 253–264.
Albritton, R. B. Cost-benefits of measles eradication: effects of a federal intervention. Policy Analysis 4 (1978) 1–21.
Centers for Disease Control Mumps — United States, 1980–1983, MMWR 32 (1983) 545–547.
Cvjetanovic, B. Cost-effectiveness and cost-benefit aspects of preventive measures against communicable diseases. In: Human rights in health. Amsterdam, ASP (Elsevier, Excerpta Medica, North Holland), pp. 187–203. Ciba Foundation Symposium 23 (New Series), 1974.
CDC: Measles Surveillance Report no. 11, 1977–1981. MMWR 31, Atlanta, 1982.
Rice, D. P., Cooper, B. S. The economic value of human life. Am. J. Public Health 57 (1967) 1954–1966.
Present status of cost-benefit analysis in the health field Am. J. Public Health 57 (1967) 1948–1953. Application of cost-benefit analysis to health systems technology. J. Occup. Med. 16 (1974) 172–186. Application of cost-benefit analysis to health services and the special case of technology innovation. Int. J. Health Serv. 4 (1974) 325–353.
Klar, H.: The economics of health. New York, London 1965. Syphilis control programmes. In:Dorfman, R. (ed.): Measuring benefits of government investments. Washington D.C. (1965) pp. 367–414.
Walgate, R.: Talloires: A quiet revolution. World Health, July 1988, pp. 28–29.
Marwick, Ch. Challenge for immunization programs: protect preschool, postschool generations. J. Amer. Med. Assoc. 260, 12 (1988) 1675–1676.
Anonymous: A corporate summit for children. The task force for child survival. The World Immunization News, 5, 1, 3, Atlanta 1989.
Bergler, R. Impfbarrieren und Impfmotivation. Vaccination: Barriers and motivations. Zentralbl. Bakteriologie, I. Abt. Originale B 180, Nr. 2–3 (1985) 190–222.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Velimirovic, B. Social, economic and psychological impacts of childhood diseases subject to immunization. Infection 19, 237–241 (1991). https://doi.org/10.1007/BF01644952
Issue Date:
DOI: https://doi.org/10.1007/BF01644952